Intrinsiqq
Ascentage Pharma Group International logo

Ascentage Pharma Group International Financials

AAPG

Compare

All currency values in ¥ millions unless otherwise noted

Scroll

Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue¥574¥981¥222¥210¥28
Cost of Revenue¥49¥29¥31¥22¥3
Gross Profit¥525¥952¥191¥188¥25
Total Operating Expenses¥1,723¥1,321¥1,064¥1,038¥894
Operating Income-¥1,198-¥370-¥873-¥850-¥870
Non-Operating
Net Interest Expense-¥54-¥64-¥96-¥53-¥17
Income Tax Expense¥7¥10-¥7-¥4-¥50
Net Income
Net Income-¥1,243-¥406-¥926-¥883-¥782
Per Share Data
Revenue Per Share¥6.45––––
EPS (Basic)-¥13.96––––
EPS (Diluted)-¥13.96––––
Shares Outstanding89.0M––––
Dividends Per Share¥0.00––––

Ascentage Pharma Group International (AAPG) financials: revenue, profit and margins

Ascentage Pharma Group International (AAPG) generated about CNY 574 million in revenue and -CNY 1.2 billion in net income (a -216.5% net margin) over the trailing twelve months, growing at roughly 113.0% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Ascentage Pharma Group International's (AAPG) revenue?+

Ascentage Pharma Group International generated about CNY 574 million in revenue over the trailing twelve months. Revenue has grown at roughly 113.0% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Ascentage Pharma Group International profitable?+

Ascentage Pharma Group International reported about -CNY 1.2 billion in net loss over the trailing twelve months, a net margin of roughly -216.5%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Ascentage Pharma Group International's profit margins?+

Ascentage Pharma Group International runs a gross margin of about 91.5%, an operating margin of about -208.6%, a net margin of about -216.5%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Ascentage Pharma Group International growing?+

Ascentage Pharma Group International's revenue has compounded at roughly 113.0% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside AAPG's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Peers

Biotechnology · Pick stocks to compare with AAPG

CompareIntrinsic value
NAVA.XOSLNavamedic ASA
€0.95-3.85%29
ELN.XMILEL.En. S.p.A.
€16.12-2.01%53
FAE.XMADFaes Farma, S.A.
€4.83-1.13%65
PIHLIS.XHELPihlajalinna Oyj
€8.30-0.95%63
LSBCFLakeShore Biopharma Co., Ltd
No recent price26
STIL.XSTOStille AB
€21.85-2.24%59
IBAB.XBRUIon Beam Applications SA
€16.06-1.59%46
VETO.XPARVetoquinol SA
€85.70-0.70%63

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing AAPG

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.